Navigation Links
Morning Sickness Drug Gets Green Light in Study
Date:6/10/2009

ter they stop taking the drug.

But, the current study focused only on short-term use during pregnancy, and Levy said that use of metoclopramide in pregnancy is "usually for short terms and as needed."

For the study, the researchers reviewed 81,703 births between 1998 and 2007, all to mothers registered with a particular Israeli health system that has a computerized database of medical information. From that group, 3,458 women -- 4.2 percent -- were given metoclopramide during the first trimester of their pregnancies.

The study found no significantly increased health risks for babies of women exposed to the drug compared with the offspring of women who hadn't taken it. The risk of birth defects, for instance, was 5.3 percent in the metoclopramide group and 4.9 percent in the group not exposed to the drug. The researchers also found no significantly increased risk of low birth weight, premature delivery or fetal death.

"We worry about women with extensive nausea and vomiting during pregnancy," said Dr. Eva Pressman, director of maternal fetal medicine at the University of Rochester Medical Center in New York. "There's concern about dehydration and losing weight. The largeness of this study is clearly better than anything we've had to date on the safety of metoclopramide, and it shows that there are safe medications that you can use in pregnancy."

Pregnant women who are having morning sickness shouldn't just suffer through it, Pressman said. Instead, she said, talk to a doctor about ways to lessen the stomach upset.

More information

The March of Dimes has more on coping with nausea during pregnancy.



SOURCES: Amalia Levy, Ph.D., senior lecturer, Department of Epidemiology and Health Service Evaluation, Ben-Gurion University of the Negev, Israel; Eva Pressman, M.D., directo
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers
2. Pro-Life Spokeswoman Objects to FDA Approval of Morning-After Pill for Minors Without Prescription
3. The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More than $800,000 in National Radiothon Benefiting St. Jude
4. Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue
5. AUDIO from Medialink and Kellogg: The Morning Blues Just Got Better
6. New Study: Protein in the Morning Helps Dieters Stay on Track and Keep Weight Off
7. US FDA Approves 30-Minute Onset of Action for Focalin(R) XR, Bringing Potential Benefits to ADHD Patients During Early Morning Period
8. Browning/Duke LLC and Medco Donate Land in Anson to Morning Dove
9. Corner stores capture kids on morning commute
10. Morningness a predictor of better grades in college
11. Morning Sickness Magic(TM) - An Effective Natural Approach to Morning Sickness

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Morning Sickness Drug Gets  Green Light in Study
Morning Sickness Drug Gets Green Light in Study
(Date:11/22/2009)... skin,s surface, bacteria are abundant, diverse an...arch at the University of California, San Diego Sc...a living on the skin surface trigger a pathway tha... "These germs are actually good for us," said Ric...pediatrics, chief of UCSD,s Division of Dermatolog...
(Date:11/22/2009)... The holiday season is filled wit... both fun and joyous. It can also be stressful and...ion of stress, fatigue, and high fat foods -- fact...cer. That,s why the National Foundation for Cancer... that can help ensure a happier, more healthful ho...
(Date:11/21/2009)... , "This bill provides for an unprecedented e...lth care about if it is not for preserving and pro... must be defeated." Charmaine Yoest ,, WASHI...s United for Life Action President and CEO Dr. Cha...nate by releasing the following statement: ,, ...
(Date:11/21/2009)... NH based medical credentialing s...its industry to form a partnerhsip with Amerinet, ...his partnership will help to transform quality car... (Vocus) November 21, 2009 -- ISG Group, L...nced a new agreement with Amerinet Inc., a leading...
(Date:11/21/2009)... Linwood Group ask whether there ...be measured? , London, UK... that with up to one in three of the adult UK popu... developing alcohol-related liver disease*, it is ...ng to rehabilitation programmes and residential ce...
Breaking Medicine News(10 mins):Health News:Surface bacteria maintain skin's healthy balance 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4
...ity, Continued Growth Seen in Election Results , ...owth and growing influence for the nation,s larges... nurses, members of the California Nurses Associat...s and other incumbent members of the CNA/NNOC Boar...
... ANGELES, May 5 Colgate and the Hispanic Dental,A...Salud Bucal: Un Mundo de,Sonrisas Saludables (Oral...rt,of an ongoing commitment to quality oral care a...t for untreated dental caries among,children, acco...
...ON CITY, N.J., May 5 Colgate and the Hispanic Den...e la Salud Bucal: Un Mundo de,Sonrisas Saludables ...as part,of an ongoing commitment to quality oral c...ighest for untreated dental caries among,children,...
... duties June 1 at ADA Chicago Headquarters...D.M.D., M.P.H, of Medford, Mass., has been selecte...Association to serve as the next ADA Executive Dir...announcement marked the end of an 11-month search ...
...UM, Md., May 5 Dialysis Corporation of America (N...r the first quarter of 2009. , , , , ... Operating revenues for the first quarter of...quarter of 2009 compared to $1.3 million for the s...
...ds rate as high as 14.7 percent in one Minnesota c... Though dyslexia and attention-deficit disorder ar... inability to write properly -- strikes a signific... an epidemiologist at the Mayo Clinic and lead aut...
Other Medicine News:Health News:CNA/NNOC Re-Elects Council of Presidents 2Health News:Colgate Bright Smiles, Bright Futures(R) Kids' Initiative Visits Los Angeles 2Health News:Colgate Bright Smiles, Bright Futures(R) Kids' Initiative Visits Union City, NJ 2Health News:Dr. Kathleen O'Loughlin Named American Dental Association Executive Director 2Health News:Dr. Kathleen O'Loughlin Named American Dental Association Executive Director 3Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 2Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 3Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 4Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 5Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 6Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 7Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 8Health News:Writing Disorder May Be Common Among Kids 2
(Date:11/20/2009)... Escalon Medical Corp. (N...fiscal first quarter ended September 30, 2009. ,... revenue decreased approximately $234,000, or 2.7%...d September 30, 2009 as compared to the same perio...eased net revenue of $8,434,000 compared with $8,6...
(Date:11/20/2009)... 20 /PRNewswire-FirstCall/ -- Landauer, Inc. (...scal fourth quarter and full year of 2009 pre-mark... will host a conference call for investors on Tues...Investors may access the live call by dialing 877-... 480-629-9835 (international callers), or by visit...
(Date:11/20/2009)...20 Reportlinker.com announces that...catalogue. ,, Pipettes & Pipettors - A Glo...inker.com/p0164373/Pipettes--Pipettors---A-Global-...utm_medium=pr&utm_campaign=prnewswire ,, ...part of any research laboratory. Large-scale appli...
Breaking Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 5976 1VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 5976 2VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 5976 3VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 5976 4Company Appoints New SVP Marketing for PBM Business 5974 1Company Appoints New SVP Marketing for PBM Business 5974 2Neuronascent Announces Collaboration with ChemRar for Characterization of Developmental Pathway Inhibitors Using Neuronascents Neurogenesis Platform 5972 1Neuronascent Announces Collaboration with ChemRar for Characterization of Developmental Pathway Inhibitors Using Neuronascents Neurogenesis Platform 5972 2
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: